Wednesday, 20 November 2013

The Thoughts of the MSIF

Thompson AJ, Chandraratna D. Multiple Sclerosis International Federation: Stimulating international cooperation in research. Neurology. 2013;81(20):1793-5. doi: 10.1212/01.wnl.0000435552.67953.c8.

The MS International Federation (MSIF), established in 1967, links the activities of over 85 national multiple sclerosis (MS) societies worldwide. Over those 45 years, and particularly in the last 20, it has seen dramatic changes in our understanding, treatment, and multidisciplinary management of people with MS. However, these advances are not universal and there are embarrassing discrepancies in the levels of treatment and care provided in different parts of the world. MSIF's research strategy is guided by an International Medical and Scientific Board composed of 70 experts in MS, nominated by our member organizations and incorporating an Executive Committee. Our strategy focuses on areas that might benefit from a global approach, those that are newly emerging, and those that are particularly challenging. We encourage young investigators to enter the field of MS research, and particularly support those from underdeveloped countries to facilitate transfer of knowledge and expertise from more "expert" areas. 
Are they doing enough?

1 comment:

  1. Many organizations such as the MSIF state that there has been dramatic changes in our understanding of MS in the last 20 years. What specifically have we learned about the pathology? The question of autoimmunity has not provided an auto-ag. Infectious etiology? Charcot project is underway. Some have postulated on microbiome (e.g. C. perfringens). What's driving progressive disease? On the positive side, re-myelination studies have advanced. Anyone have other thoughts on last 20 years of research?


Please note that all comments are moderated and any personal or marketing-related submissions will not be shown.